San Diego, CA, United States of America

Eric V Schmid

USPTO Granted Patents = 55 


 

Average Co-Inventor Count = 3.9

ph-index = 19

Forward Citations = 1,230(Granted Patents)

Forward Citations (Not Self Cited) = 1,073(Dec 10, 2025)


Location History:

  • Los Angeles, CA (US) (2006 - 2021)
  • San Diego, CA (US) (1999 - 2022)
  • Irvine, CA (US) (2017 - 2023)

Company Filing History:


Years Active: 1999-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Neurostimulation
Electromyography
Nerve Stimulation
Embolotherapy
Polymeric Products
Clinician Programmer
Expandable Stents
Medical Applications
Remote Patient Monitoring
Electrode Configurations
Trial Nerve Stimulation
Vulcanization
55 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Eric V Schmid**

Introduction

Eric V Schmid, based in San Diego, California, is an accomplished inventor with a total of 34 patents to his name. His extensive work in the field of biomedical engineering has significantly contributed to advancements in embolotherapy, showcasing his commitment to innovation and improving patient outcomes.

Latest Patents

Among his latest innovations are the patents for "Inherently Radiopaque Polymeric Products for Embolotherapy." These patents involve compositions of inherently radiopaque, biocompatible, and bioresorbable polymeric particles designed for effectively embolizing a body lumen. This work reflects Eric's focus on creating materials that enhance the efficacy of medical procedures while ensuring biocompatibility for patient safety.

Career Highlights

Eric has made substantial contributions throughout his career, having worked with notable companies such as Reva Medical, Inc. and Apex Medical Technologies, Inc. His experience in these organizations has allowed him to apply his research and drive innovation in the medical technology sector, leading to significant advancements in treatment methodologies.

Collaborations

Throughout his career, Eric has collaborated with esteemed colleagues such as Andrew Morris and Joan Zeltinger. These partnerships have enriched his research endeavors, fostering a collaborative environment that promotes inventive solutions to complex medical challenges.

Conclusion

Eric V Schmid's dedication to innovation and the development of biocompatible materials for use in embolotherapy illustrates the impact of his work in the medical field. With an impressive portfolio of patents and a collaborative professional journey, Eric continues to inspire advancements that change lives for the better.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…